Evaluation of OE-MRI in Patients With H&N Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1
JAB-3068 Activity in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use
- Status
- COMPLETED
- Phase
- NA
Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of NKTR 255 in Combination With Cetuximab in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Specific Methylation Profiles in HNSCC
- Status
- RECRUITING
- Phase
- N/A
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
- Status
- RECRUITING
- Phase
- N/A
Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Concurrent Immunotherapy With Postoperative Radiotherapy in Intermediate/High Risk HNSCC Patients Unfit for Cisplatin: The IMPORT Study (IMPORT)
- Status
- UNKNOWN
- Phase
- PHASE2
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
- Status
- COMPLETED
- Phase
- N/A
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1